Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis. | Cell Rep Med | 2023 | 38118422 | PubTator, text mining | PubMed |
| Separation of GVL from GVHD -location, location, location. | Front Immunol | 2023 | 38116007 | PubTator, text mining | PubMed |
| Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases. | J Immunol Res | 2023 | 38106519 | PubTator, text mining | PubMed |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy. | Front Immunol | 2023 | 38090565 | PubTator, text mining | PubMed |
| The expanding Pandora's toolbox of CD8+T cell: from transcriptional control to metabolic firing. | J Transl Med | 2023 | 38082437 | PubTator, text mining | PubMed |
| Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy. | Front Immunol | 2023 | 38077389 | PubTator, text mining | PubMed |
| Expression of Tumor Suppressor FHIT Is Regulated by the LINC00173-SNAIL Axis in Human Lung Adenocarcinoma. | Int J Mol Sci | 2023 | 38069335 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma. | Cancers (Basel) | 2023 | 38067356 | PubTator, text mining | PubMed |
| Molecular and Functional Characterization of α Chain of Interleukin-15 Receptor (IL-15Rα) in Orange-Spotted Grouper (Epinephelus coioides) in Response to Vibrio harveyi Challenge. | Animals (Basel) | 2023 | 38066992 | PubTator, text mining | PubMed |
| iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting. | J Immunother Cancer | 2023 | 38056893 | PubTator, text mining | PubMed |
| TGFß1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for Breast Cancer Cells with Mesenchymal Properties. | J Mammary Gland Biol Neoplasia | 2023 | 38055067 | PubTator, text mining | PubMed |
| New insights into the stemness of adoptively transferred T cells by γc family cytokines. | Cell Commun Signal | 2023 | 38049832 | PubTator, text mining | PubMed |
| Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer. | Cancer Med | 2023 | 38037752 | PubTator, text mining | PubMed |
| Derived myeloid lineage induced pluripotent stem as a platform to study human C-C chemokine receptor type 5Δ32 homozygotes. | iScience | 2023 | 38026202 | PubTator, text mining | PubMed |
| Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment. | Front Oncol | 2023 | 38023191 | PubTator, text mining | PubMed |
| Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment. | Front Immunol | 2023 | 38022679 | PubTator, text mining | PubMed |
| Inhibition of T-cell activity in alopecia areata: recent developments and new directions. | Front Immunol | 2023 | 38022501 | PubTator, text mining | PubMed |
| Single-cell transcriptomic atlas of distinct early immune responses induced by SARS-CoV-2 Proto or its variants in rhesus monkey. | MedComm (2020) | 2023 | 38020713 | PubTator, text mining | PubMed |
| CAR+ and CAR- T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies. | Nat Commun | 2023 | 38012187 | PubTator, text mining | PubMed |
| Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. | Proc Natl Acad Sci U S A | 2023 | 38011564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=10